Safety and Efficacy of Daratumumab with Lenalidomide and Dexamethasone in Relapsed or Relapsed, Refractory Multiple Myeloma

被引：31

作者：

Plesner, Torben ^{[1
]}

Arkenau, Hendrik-Tobias ^{[2
]}

Lokhorst, Henk M. ^{[3
]}

Gimsing, Peter ^{[4
]}

Krejcik, Jakub ^{[1
]}

Lemech, Charlotte ^{[5
]}

Minnema, Monique C. ^{[3
]}

Lassen, Ulrik ^{[6
]}

Laubach, Jacob P. ^{[7
]}

Ahmadi, Tahamtan ^{[8
]}

Yeh, Howard ^{[9
]}

Guckert, Mary E. ^{[8
]}

Feng, Huaibao ^{[9
]}

Brun, Nikolai Constantin ^{[10
]}

Lisby, Steen ^{[11
]}

Basse, Linda ^{[10
]}

Palumbo, Antonio ^{[12
]}

Richardson, Paul G. ^{[13
,14
]}

机构：

[1] Vejle Hosp, Velje, Denmark

[2] Sarah Cannon Res Insitute, London, England

[3] UMC Utrecht, Utrecht, Netherlands

[4] Univ Copenhagen, Copenhagen, Denmark

[5] Sarah Cannon Res Inst, London, England

[6] Rigshosp, DK-2100 Copenhagen, Denmark

[7] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA

[8] Janssen, Spring House, PA USA

[9] Janssen Res & Dev, Raritan, NJ USA

[10] Genmab AS, Copenhagen, Denmark

[11] Genmab, Copenhagen, Denmark

[12] Univ Turin, Myeloma Unit, Div Hematol, Turin, Italy

[13] Harvard Univ, Sch Med, Dana Farber Canc Inst, LeBow Inst Myeloma Therapeut,Dept Med Oncol, Boston, MA 02115 USA

[14] Harvard Univ, Sch Med, Dana Farber Canc Inst, Jerome Lipper Myeloma Ctr,Dept Med Oncol, Boston, MA 02115 USA

来源：

BLOOD | 2014年 / 124卷 / 21期

关键词：

D O I：

10.1182/blood.V124.21.84.84

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：3

共 50 条

[21] EFFICACY AND SAFETY OF LENALIDOMIDE AND DEXAMETHASONE IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A REAL LIFE EXPERIENCE
Soyer, N.
Patir, P.
Uysal, A.
Duran, M.
Unal, H. D.
Tombuloglu, M.
Sahin, F.
Vural, F.
Saydam, G.
[J]. LEUKEMIA RESEARCH, 2016, 49 : S36 - S36
[22] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients - real world evidence analysis
Stork, Martin
Spicka, Ivan
Radocha, Jakub
Minarik, Jiri
Jelinek, Tomas
Jungova, Alexandra
Pavlicek, Petr
Pospisilova, Lenka
Sedlak, Frantisek
Straub, Jan
Pika, Tomas
Knechtova, Zdenka
Fidrichova, Anna
Boichuk, Ivanna
Sevcikova, Sabina
Maisnar, Vladimir
Hajek, Roman
Pour, Ludek
[J]. ANNALS OF HEMATOLOGY, 2023, 102 (06) : 1501 - 1511
[23] Daratumumab with lenalidomide and dexamethasone in relapsed or refractory multiple myeloma patients – real world evidence analysis
Martin Stork
Ivan Spicka
Jakub Radocha
Jiri Minarik
Tomas Jelinek
Alexandra Jungova
Petr Pavlicek
Lenka Pospisilova
Frantisek Sedlak
Jan Straub
Tomas Pika
Zdenka Knechtova
Anna Fidrichova
Ivanna Boichuk
Sabina Sevcikova
Vladimir Maisnar
Roman Hajek
Ludek Pour
[J]. Annals of Hematology, 2023, 102 : 1501 - 1511
[24] EFFICACY AND SAFETY OF LENALIDOMIDE IN COMBINATION WITH DEXAMETASONE IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
Canovas, A.
Alonso, J. J.
Barreiro, B.
[J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 625 - 625
[25] Expanded safety experience with lenalidomide plus dexamethasone in relapsed or refractory multiple myeloma
Chen, Christine
Reece, Donna E.
Siegel, David
Niesvizky, Ruben
Boccia, Ralph V.
Stadtmauer, Edward A.
Abonour, Rafat
Richardson, Paul
Matous, Jeffrey
Kumar, Shaji
Bahlis, Nizar J.
Alsina, Melissa
Vescio, Robert
Coutre, Steven E.
Pietronigro, Dennis
Knight, Robert D.
Zeldis, Jerome B.
Rajkumar, Vincent
[J]. BRITISH JOURNAL OF HAEMATOLOGY, 2009, 146 (02) : 164 - 170
[26] Daratumumab plus pomalidomide and dexamethasone in relapsed and/or refractory multiple myeloma
Chari, Ajai
Suvannasankha, Attaya
Fay, Joseph W.
Arnulf, Bertrand
Kaufman, Jonathan L.
Ifthikharuddin, Jainulabdeen J.
Weiss, Brendan M.
Krishnan, Amrita
Lentzsch, Suzanne
Comenzo, Raymond
Wang, Jianping
Nottage, Kerri
Chiu, Christopher
Khokhar, Nushmia Z.
Ahmadi, Tahamtan
Lonial, Sagar
[J]. BLOOD, 2017, 130 (08) : 974 - 981
[27] Lenalidomide plus dexamethasone demonstrates efficacy in the treatment of relapsed or refractory multiple myeloma
不详
[J]. FORMULARY, 2008, 43 (02) : 79 - 80
[28] Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
Gasparetto, Cristina
Lentzsch, Suzanne
Schiller, Gary
Callander, Natalie
Tuchman, Sascha
Chen, Christine
White, Darrell
Kotb, Rami
Sutherland, Heather
Sebag, Michael
Baljevic, Muhamed
Bensinger, William
Leblanc, Richard
Venner, Chris
Bahlis, Nizar
Rossi, Adriana
Biran, Noa
Sheehan, Heidi
Saint-Martin, Jean-Richard
Van Domelen, Dane
Kai, Kazuharu
Shah, Jatin
Shacham, Sharon
Kauffman, Michael
Lipe, Brea
[J]. EJHAEM, 2021, 2 (01): : 56 - 65
[29] Efficacy of lenalidomide plus dexamethasone in relapsed/refractory multiple myeloma: A systematic review
Tandy, Fenia
Hadisurya, Audrey
Suciningtias, Marlyn
Chrystelle, Celine
Kurniawan, Andree
[J]. ANNALS OF ONCOLOGY, 2022, 33 : S489 - S489
[30] Daratumumab, lenalidomide, and dexamethasone in relapsed/refractory myeloma: a cytogenetic subgroup analysis of POLLUX
Jonathan L. Kaufman
Meletios A. Dimopoulos
Darrell White
Lotfi Benboubker
Gordon Cook
Merav Leiba
James Morton
P. Joy Ho
Kihyun Kim
Naoki Takezako
Philippe Moreau
Heather J. Sutherland
Hila Magen
Shinsuke Iida
Jin Seok Kim
H. Miles Prince
Tara Cochrane
Albert Oriol
Nizar J. Bahlis
Ajai Chari
Lisa O’Rourke
Sonali Trivedi
Tineke Casneuf
Maria Krevvata
Jon Ukropec
Rachel Kobos
Hervé Avet-Loiseau
Saad Z. Usmani
Jesus San-Miguel
[J]. Blood Cancer Journal, 10

← 1 2 3 4 5 →